Private Equity
Correlation Ventures has raised about $188 million for its second fund, according to an SEC filing. The California-based venture firm closed its previous fund at $165 million.
1 min read · 28 July 2016
Canadian agricultural products and services company Agrium Inc (TSX, NYSE: AGU) has made an undisclosed commitment to the second agricultural technology fund of U.S. venture capital firm Finistere Ventures. Finistere Ventures Fund II, targeted to raise US$150 million, will invest in companies in plant nutrition, biologicals, seed technology, digital agriculture and novel farm systems. Agrium said the commitment will enhance its "ability to access and evaluate the pipeline of rapidly evolving agricultural technologies." AVAC said last year it is partnering with Finistere to help leverage opportunities emerging from Canadian universities and research institutions.
3 min read · 27 July 2016
Peak Ventures is launching its second fund, according to an SEC filing. The target is not specified.
1 min read · 27 July 2016
Finistere Ventures has raised over $60 million for its second fund, according to an SEC filing. The target is $200 million.
1 min read · 27 July 2016
Felicis founder peers beyond simple revenue traction to examine sales per invested dollar and employee
5 min read · 27 July 2016
Just 33 transactions were completed in Q2, another sign that early-stage cleantech investing remains out of favor
2 min read · 27 July 2016
A summary of recent funds closed worldwide, such as Lonsdale 8VC, 500 Startups, Capricorn Venture Partners and Alchemy Ventures
7 min read · 26 July 2016
Maiden Lane has set out to raise a second fund, according to a filing with the SEC.
1 min read · 26 July 2016
Volition Capital has raised $250 million for its third growth equity fund. As with its previous funds, Volition Capital Fund III will target high growth tech companies. Volition will make investments between $5 million and $40 million per company.
2 min read · 26 July 2016
A total of 18 VC-backed companies were acquired in June, led by the outsized Stemcentrx deal
1 min read · 25 July 2016
